WHO ICTRP trial
Effect of Early Switch to Oral Antibiotic Therapy on Treatment Outcomes in…
KCT0011147 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0011147 |
|---|---|
| Public title | Effect of Early Switch to Oral Antibiotic Therapy on Treatment Outcomes in Patients with Spondylitis |
| Scientific title | Early Oral Switch versus Continued Intravenous Therapy in Hematogenous Vertebral Osteomyelitis |
| Primary sponsor | Asan Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase3 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the musculoskeletal system and connective tissue |
| Interventions | Drug : 1) Intervention Group (Early Oral-Switch Group) After receiving intravenous (IV) antibiotic therapy for 14 ± 2 days, patients whose infection is deemed clinically stable will be switched to a highly bioavailable oral antibiotic… |
| Registration date | Nov 12, 2025 |
| Target size | 302 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: